Randomized Controlled Trial
Copyright ©2014 Baishideng Publishing Group Inc.
World J Diabetes. Dec 15, 2014; 5(6): 962-968
Published online Dec 15, 2014. doi: 10.4239/wjd.v5.i6.962
Table 1 Baseline characteristics of the study participants1
CharacteristicInterventionControlP2
n = 19n = 17
Age in years51.9 ± 8.251.1 ± 13.80.710
Sex, M:F6:135:120.433
Weight at study baseline in kg75.79 ± 9.0273.38 ± 11.980.550
Weight at end-of-trial in kg75.84 ± 9.0473.12 ± 11.890.750
BMI at study baseline in kg/m227.36 ± 4.2328.58 ± 4.70.330
Duration of diabetes5.96 ± 5.19.00 ± 7.20.120
Fasting blood glucose in mg/dL160.5 ± 51.3201.7 ± 89.20.090
HbA1C, %7.2 ± 1.67.5 ± 1.90.740
Waist circumference in cm99.13 ± 9.06100.56 ± 8.060.680
Hypoglycemic agent use, n (%)17 (89.5)14 (82.3)0.4233
Anti-hypertension agent use, n (%)5 (26.13)3 (17.46)0.2533